Is intravesical chemotherapy for superficial bladder cancer still justified?
- 9 September 2005
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 96 (6), 763-767
- https://doi.org/10.1111/j.1464-410x.2005.05711.x
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Intravesical Bacillus Calmette-Guerin Versus Mitomycin C For Superficial Bladder Cancer: A Formal Meta-Analysis of Comparative Studies on Recurrence and ToxicityJournal of Urology, 2003
- INTRAVESICAL INSTILLATION OF EPIRUBICIN, BACILLUS CALMETTE-GUERIN AND BACILLUS CALMETTE-GUERIN PLUS ISONIAZID FOR INTERMEDIATE AND HIGH RISK TA, T1 PAPILLARY CARCINOMA OF THE BLADDERJournal of Urology, 2001
- LOW DOSE BACILLUS CALMETTE-GUERIN FOR CARCINOMA IN SITU OF THE BLADDER:Journal of Urology, 2000
- BLADDER CANCER CLINICAL GUIDELINES PANEL SUMMARY REPORT ON THE MANAGEMENT OF NONMUSCLE INVASIVE BLADDER CANCER (STAGES Ta, T1 AND TIS)Journal of Urology, 1999
- Long-Term Efficacy of Intravesical Bacillus Calmette-Guerin for Carcinoma in SituJournal of Urology, 1997
- A Combined Analysis of European Organization for Research and Treatment of Cancer, and Medical Research Council Randomized Clinical Trials for the Prophylactic Treatment of Stage TaT1 Bladder CancerJournal of Urology, 1996
- A Randomized Multicenter Trial of Adjuvant Therapy in Superficial Bladder CancerJournal of Urology, 1996
- A Randomized Prospective Study Comparing Long-Term Intravesical Instillations of Mitomycin C and Bacillus Calmette-Guerin in Patients with Superficial Bladder CarcinomaJournal of Urology, 1996
- Apparent Failure of Current Intravesical Chemotherapy Prophylaxis to Influence the Long-Term Course of Superficial Transitional Cell Carcinoma of the BladderJournal of Urology, 1995
- Original ArticlesJournal of Urology, 1995